Systematic review: persistence and severity in gastro‐oesophageal reflux disease

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2008-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2036.2008.03804.xPMID 18637097
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden

  2012cited by this paper
• WITHDRAWN: Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.

  2010cited by this paper
• Impact of Gastroesophageal Reflux on Survival in the Community

  2008cited by this paper
• Mortality associated with gastroesophageal reflux disease and its non-malignant complications: a systematic review

  2008cited by this paper
• Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano–Monghidoro study

  2008cited by this paper
• Review article: the pathophysiology of gastro‐oesophageal reflux disease

  2007cited by this paper
• Time trends of gastroesophageal reflux disease: a systematic review.

  2007cited by this paper
• Long‐term treatment of patients with gastro‐oesophageal reflux disease in routine care – results from the ProGERD study

  2007cited by this paper
• Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia

  2006cited by this paper
• Barrett's Esophagus and Medications that Relax the Lower Esophageal Sphincter

  2006cited by this paper
• Body Mass Index and Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis

  2006cited by this paper
• Lifestyle factors and symptoms of gastro‐oesophageal reflux – a population‐based study

  2006cited by this paper
• Obesity: a challenge to esophagogastric junction integrity.

  2006cited by this paper
• The Long-Term Natural History of Gastroesophageal Reflux Disease

  2006cited by this paper
• Prospective Follow-Up Data from the ProGERD Study Suggest that GERD Is Not a Categorial Disease

  2006cited by this paper
• Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care

  2006cited by this paper
• Does the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey‐based study

  2006cited by this paper
• The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus

  2006cited by this paper
• Gastroesophageal Reflux Symptoms and Well-Being in a Random Sample of the General Population of a Swedish Community

  2006cited by this paper
• Gastro‐oesophageal reflux symptoms and health‐related quality of life in the adult general population – the Kalixanda study

  2006cited by this paper
• CYP2C19 genotype and the PPIs – focus on rabeprazole

  2005cited by this paper
• Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.

  2005cited by this paper
• Changing prevalence of gastroesophageal reflux with changing time: Longitudinal study in an Asian population

  2005cited by this paper
• Epidemiology of gastro-oesophageal reflux disease: a systematic review

  2005cited by this paper
• Obesity Is an Independent Risk Factor for GERD Symptoms and Erosive Esophagitis

  2005cited by this paper
• Occurrence and future history of oesophageal symptoms in an urban Swedish population: Results of a questionnaire-based, ten-year follow-up study

  2005cited by this paper
• High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report

  2005cited by this paper
• Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia–Pacific region: The FAST survey

  2004cited by this paper
• Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

  2004cited by this paper
• Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus

  2004cited by this paper
• Natural history of gastro‐oesophageal reflux disease diagnosed in general practice

  2004cited by this paper
• Childhood GERD is a Risk Factor for GERD in Adolescents and Young Adults

  2004cited by this paper
• Changing epidemiology of gastroesophageal reflux disease in the Asian–Pacific region: An overview

  2004cited by this paper
• Symptoms of gastro‐oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population

  2004cited by this paper
• Onset and disappearance of reflux symptoms in a Chinese population: a 1‐year follow‐up study

  2004cited by this paper
• Gastroesophageal Reflux Disease: A Typical Spectrum Disease (A New Conceptual Framework is Not Needed)

  2004cited by this paper
• Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association

  2003cited by this paper
• The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study

  2003cited by this paper
• Prevalence of extra‐oesophageal manifestations in gastro‐oesophageal reflux disease: an analysis based on the ProGERD Study

  2003cited by this paper
• Risk factors for Barrett's esophagus: A case‐control study

  2002cited by this paper
• Clinical characteristics and natural history of patients with low‐grade reflux esophagitis

  2002cited by this paper
• Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.

  2001cited by this paper
• Assessing NSAID Prescription Use as a Predisposing Factor for Gastroesophageal Reflux Disease in a Medicaid Population

  2001cited by this paper
• Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study

  2001cited by this paper
• Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

  1999cited by this paper
• [Epidemiology of gastro-esophageal-reflux in general practice. . Predictive factors for health care utilization in the course of a year].

  1999cited by this paper
• Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients.

  1997cited by this paper
• Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy.

  1997cited by this paper
• Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

  1997cited by this paper
• Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time.

  1995cited by this paper
• Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders.

  1992cited by this paper
• Healing and relapse of severe peptic esophagitis after treatment with omeprazole.

  1988cited by this paper

• Drug treatment strategies for erosive esophagitis in adults: a narrative review

  2025cites this paper
• Follow-up study of vonoprazan maintenance therapy for reflux esophagitis: A 96-week evaluation in patients with PPI-refractory disease

  2025cites this paper
• S2k guideline Gastroesophageal reflux disease and eosinophilic esophagitis of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)

  2024cites this paper
• Chinese consensus on multidisciplinary diagnosis and treatment of gastroesophageal reflux disease 2022 gastroesophageal reflux disease committee, China international exchange and Promotive Association for medical and health care

  2023cites this paper
• Long-Term Clinical Course after Successful Initial Treatment in Patients with Mild Erosive Esophagitis: A Prospective Follow-Up Study

  2023cites this paper
• S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013

  2023cites this paper
• Endodontic treatment of traumatized teeth with chronic periapical lesions using antibiotic paste and mineral trioxide aggregate obturation - a preliminary study

  2019cites this paper
• Prevalence and risk factors for Barrett’s esophagus in patients with chronic gastroesophageal reflux disease

  2019cites this paper
• Efficacy of Vonoprazan for 48-Week Maintenance Therapy of Patients with Healed Reflux Esophagitis

  2019cites this paper
• Discontinuing Long-Term PPI Therapy: Why, With Whom, and How?

  2018cites this paper
• Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study

  2017cites this paper
• Epidemiology and Socioeconomics of Reflux Disease

  2015cites this paper
• Management of reflux esophagitis: does the choice of proton pump inhibitor matter?

  2015cites this paper
• Difference in efficacy of proton pump inhibitor between new-onset and recurrent gastroesophageal reflux disease: Result from a study of on-demand versus continuous maintenance therapy in Japan.

  2015cites this paper
• 2. Zielorientierung der Leitlinie

  2014cites this paper
• [S2k guideline: gastroesophageal reflux disease guided by the German Society of Gastroenterology: AWMF register no. 021-013].

  2014cites this paper
• Prevalence and Risk Factors for Barrett’s Esophagus in Patients with GERD in Northern India; Do Methylene Blue-directed Biopsies Improve Detection of Barrett’s Esophagus Compared the Conventional Method?

  2014cites this paper
• S2k-Leitlinie: Gastroösophageale Refluxkrankkheit unter Federführung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

  2014cites this paper
• A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan

  2014cites this paper
• Reflux disease and Achalasia

  2013cites this paper
• What is the role of endoscopy and oesophageal biopsies in the management of GERD?

  2013cites this paper
• Chapter 5 Randomized clinical trial : effect of a novel metabotropic glutamate receptor 5 antagonist ( AZD 2066 ) on transient lower esophageal sphincter relaxations and reflux episodes in healthy volunteers

  2013cites this paper
• Reflux disease and achalasia: Failure of the gatekeeper

  2013cites this paper
• Gestational age and size at birth and risk of esophageal inflammation and cancer

  2013cites this paper
• Novel surgical concept in antireflux surgery: long-term outcomes comparing 3 different laparoscopic approaches.

  2012cites this paper
• The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers

  2012cites this paper
• Gestational age at birth and risk of gastric acid-related disorders in young adulthood.

  2012cites this paper
• Initiation and duration of proton pump inhibitors in the Australian veteran population

  2012cites this paper
• Review of the persistence of gastroesophageal reflux disease in children, adolescents and adults: does gastroesophageal reflux disease in adults sometimes begin in childhood?

  2011cites this paper
• Perspectives on gastroesophageal reflux disease in primary care: the REFLEX study of patient-physician agreement

  2011cites this paper
• Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: The systematic investigation of gastrointestinal diseases in China (SILC)

  2011cites this paper
• Revisión sistemática: epidemiología de la enfermedad por reflujo gastroesofágico en Latinoamérica

  2011cites this paper
• For Peer Review Depression and treatment with antidepressants are associated with the development of gastroesophageal reflux

  2010cites this paper
• 2. Gastroesophageal Reflux Disease

  2010cites this paper
• Maintenance therapy of gastroesophageal reflux disease

  2010cites this paper
• A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in China

  2010cites this paper
• Gastrointestinal Complications of Solid Organ and Hematopoietic Cell Transplantation

  2010cites this paper
• Effect of lesogaberan, a novel GABAB‐receptor agonist, on transient lower oesophageal sphincter relaxations in male subjects

  2010cites this paper
• PEGAFERON IN HEPATITIS C: RESULTS OF A MULTICENTER STUDY

  2010cites this paper
• Depression and treatment with antidepressants are associated with the development of gastro‐oesophageal reflux disease

  2010cites this paper
• Gastroesophageal reflux disease in children and adolescents in primary care

  2010cites this paper
• Canadian Digestive Health Foundation Public Impact Series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impact.

  2010cites this paper
• Patient and Physician Satisfaction with Proton Pump Inhibitors (PPIs): Are There Opportunities for Improvement?

  2010cites this paper
• Maintenance Treatment With Proton Pump Inhibitors for Reflux Esophagitis in Pediatric Patients: A Systematic Literature Analysis

  2010cites this paper
• Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs?

  2010cites this paper
• Follow-up of a cohort of children and adolescents with gastro-esophageal reflux disease who were free of reflux esophagitis at initial diagnosis

  2010cites this paper
• A Critical Assessment of the Current Status of Non-Erosive Reflux Disease

  2008influential citation
• S2k-Leitlinie: Gastroösophageale Refluxkrankkheit unter Federführung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten (DGVS)* AWMF Register Nr. 021-013 S2k Guideline: Gastroesophageal Reflux Disease Guided by the German Society of Gastroenterology

  year unknowncites this paper